Justin Rectenwald, a Biochemistry and Biophysics PhD alumnus (Pearce/Frye Lab), recently rejoined Taysha Gene Therapies as a Senior Manager, CMC Analytical Development role. Taysha Gene Therapies is focused on developing and commercializing therapies for the treatment of monogenic diseases of the central nervous system. At Taysha he is responsible for managing the analytical methods and strategy required for product development and release. He is also responsible for supporting studies important for regulatory submissions such as stability and degradation studies through analytical testing. For this role, Justin leverages his technical training and experience from a multitude of biophysical, biochemical, and molecular biology methods. If you’re interested in learning more about Justin’s position or path, please feel free to reach out to him on LinkedIn. – November 2023